Paracentral acute middle maculopathy: precursor to macular thinning in sickle cell retinopathy

Syed Amal Hussnain1, Patrick A Coady1,2, Kathleen M Stoessel1

  • 1Department of Ophthalmology and Visual Science, Yale University School of Medicine, New Haven, Connecticut, USA.

BMJ Case Reports
|April 28, 2017
PubMed

Insights

Paracentral acute middle maculopathy (PAMM) may precede macular thinning in sickle cell disease (SCD). This early vascular damage in the deep capillary plexus might be missed by fluorescein angiography.

Area of Science:

  • Ophthalmology
  • Hematology
  • Retinal Vascular Diseases

Background:

  • Sickle cell disease (SCD) is a systemic disorder that can affect the eyes, leading to various complications.
  • Retinopathy in SCD is often characterized by gradual capillary loss and neovascularization.
  • Macular thinning is a common finding in patients with advanced sickle cell retinopathy.

Observation:

  • A case of paracentral acute middle maculopathy (PAMM) was identified in a patient with sickle cell disease.
  • PAMM involves acute damage to the superficial and intermediate capillary plexuses.
  • The affected area in this case was the macula, crucial for central vision.

Findings:

  • The presented case suggests PAMM could be an early, precursor lesion to the macular thinning typically seen in sickle cell disease.
  • This indicates that acute vascular events, not just gradual loss, may play a role in SCD pathophysiology.
  • Fluorescein angiography may not detect these acute vascular changes occurring in the deep capillary plexus.

Implications:

  • Recognizing PAMM as a potential precursor lesion could lead to earlier diagnosis and intervention in sickle cell retinopathy.
  • This finding may necessitate the development of novel imaging techniques or diagnostic criteria for early detection.
  • Understanding PAMM's role could refine our understanding of the vascular complications of sickle cell disease.

Related Concept Videos